MS treatment showdown: does starting strong early prevent disability?
NCT ID NCT03500328
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial compares two treatment strategies for people with relapsing-remitting multiple sclerosis: starting with high-efficacy drugs early versus starting with standard first-line therapies and switching if needed. The study involves 900 participants across multiple sites and tracks disability progression over time. The goal is to determine whether early aggressive therapy better prevents long-term disability.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multiple FDA-approved MS drugs (e.g., natalizumab, ocrelizumab, glatiramer acetate, interferons)
What this could lead to
If successful, this could show that starting with stronger drugs early on helps prevent disability in people with relapsing-remitting MS.
What could go wrong
This is a large pragmatic trial, but results may not apply to all MS patients. Higher-efficacy drugs carry infection risks and other side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Neurology Specialists
Great Falls, Montana, 59405, United States
-
Allegheny Health Network Research Institute
Pittsburgh, Pennsylvania, 15212, United States
-
Baylor Scott and White Health
Dallas, Texas, 75246, United States
-
Billings Clinic
Billings, Montana, 59101, United States
-
Blacksburg Neurology
Christiansburg, Virginia, 24073, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Central Texas Neurology Consultants
Round Rock, Texas, 78681, United States
-
Christiana Care Health Services, Inc.
Newark, Delaware, 19713, United States
-
Columbia University Medical Center
New York, New York, 10032, United States
-
CommonSpirit Health Research Institute
Carmichael, California, 95608, United States
-
Geisinger Clinic
Danville, Pennsylvania, 17822, United States
-
Georgetown University
Washington D.C., District of Columbia, 20007, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Neurology Consultants of Tidewater
Norfolk, Virginia, 23502, United States
-
New York University School of Medicine
New York, New York, 10016, United States
-
Norton Neurology MS Services
Louisville, Kentucky, 40207, United States
-
OhioHealth Research Institute
Columbus, Ohio, 43214, United States
-
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma, 73104, United States
-
Providence Health and Services - Oregon
Portland, Oregon, 97225, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
St. Joseph's Hospital & Medical Center - Barrow Neurological Institute
Phoenix, Arizona, 85013, United States
-
Swedish Health Services
Seattle, Washington, 98122, United States
-
The Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
The University of Kansas Medical Center (KUMC)
Kansas City, Kansas, 66160, United States
-
The University of South Alabama
Mobile, Alabama, 36604, United States
-
The University of Vermont and State Agricultural College
Burlington, Vermont, 05405, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
-
University of California, San Diego
San Diego, California, 92037, United States
-
University of California, San Francisco
San Francisco, California, 94158, United States
-
University of Cincinnati
Cincinnati, Ohio, 45219, United States
-
University of Florida
Gainesville, Florida, 32611, United States
-
University of Maryland, Baltimore
Baltimore, Maryland, 21201, United States
-
University of Massachusetts Medical School
Worcester, Massachusetts, 01655, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of South Florida Health
Tampa, Florida, 33612, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-8806, United States
-
University of Utah
Salt Lake City, Utah, 84108, United States
-
University of Washington
Seattle, Washington, 98133, United States
-
Vanderbilt Comprehensive MS Center
Nashville, Tennessee, 37215, United States
-
Wayne State University
Detroit, Michigan, 48201, United States